마크로젠 로고

June 18, 2025 - Macrogen announced that Dr. Seungbeen Lee, CSO, presented at the Illumina Korea Press Conference held today in Seoul. His talk, titled "The $100 Genome and 100-Year Health: AI-Driven Digital Healthcare Revolution," highlighted Macrogen’s strategic transition into an AI- and data-driven precision medicine company.

March 31, 2025 - Macrogen Inc. (CEO Changhoon Kim), a global leader in digital healthcare, announced the official launch of its GenTok platform integrated with Samsung Health. Following an official service agreement signed with Samsung Electronics in November last year, Macrogen has been preparing a healthcare service on genetic testing. Through this integration, users can now combine their daily health data—such as exercise, sleep, and body composition—with genetic insights from GenTok to receive a more personalized and optimized health guide.

December 9, 2024 -Macrogen, a global leader in genomic analysis, in partnership with DNA Link, Theragen Bio, and CG invites, has been selected as the final contractor forNational Integrated Bio Big Data Project, supported by the Ministry of Health and Welfare and the Korea Disease Control and Prevention Agency, and commissioned by the Korea Research Institute of Bioscience and Biotechnology.